Gossamer Bio (STU:4GB) Ending Cash Position : €44.0 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gossamer Bio Ending Cash Position?

Gossamer Bio's Ending Cash Position for the quarter that ended in Dec. 2024 was €44.0 Mil.

Gossamer Bio's quarterly Ending Cash Position declined from Jun. 2024 (€80.7 Mil) to Sep. 2024 (€25.6 Mil) but then increased from Sep. 2024 (€25.6 Mil) to Dec. 2024 (€44.0 Mil).

Gossamer Bio's annual Ending Cash Position declined from Dec. 2022 (€105.7 Mil) to Dec. 2023 (€29.4 Mil) but then increased from Dec. 2023 (€29.4 Mil) to Dec. 2024 (€44.0 Mil).

Gossamer Bio Ending Cash Position Historical Data

The historical data trend for Gossamer Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gossamer Bio Ending Cash Position Chart

Gossamer Bio Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

400.00

162.37

105.70

29.44

44.00

Gossamer Bio Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															29.44	35.75	80.71	25.65	44.00

Gossamer Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Gossamer Bio's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	30.664	+	13.337
	=	44.0

Gossamer Bio's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	27.183	+	16.818
	=	44.0

Gossamer Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Gossamer Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Gossamer Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gossamer Bio Inc (STU:4GB) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

GOSS:USA 4GB:Germany

Address

3115 Merryfield Row, Suite 120, San Diego, CA, USA, 92121

Website

https://www.gossamerbio.com

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Gossamer Bio Headlines

No Headlines